Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOTICStandard

CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE

CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE

Standard Dose
EQ 0.2% BASE;1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE is listed in Drugs@FDA under application 218273 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE Form and strength SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1% Sponsor COSETTE PHARMS NC Submission history Latest submission status date: 2025-11-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE is listed in Drugs@FDA under application 218273 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE Form and strength SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1% Sponsor COSETTE PHARMS NC Submission history Latest submission status date: 2025-11-10 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.